Clinical Trial Update: Correlation Between RISANKIZUMAB's Trough Levels, Clinical and Biological Remission in Moderate to Severe Crohn's Disease: a Retrospective Multicentric Study

View source ↗

Summary

A retrospective multicenter study evaluating the relationship between risankizumab trough levels and clinical/biological remission in adults with moderate-to-se…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• SKYRIZI (risankizumab-rzaa)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Inflammatory Bowel Diseases | Status: COMPLETED